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Abstract 
GSK3β is a serine threonine kinase that has been shown to influence 
numerous biological and psychological interactions, including the regulation of 
cell survival and cell death, as well as influencing mood disorders such as major 
depressive disorder and bipolar disorder. Preliminary data from our lab showed an 
exaggerated conditioned fear response in homozygous GSK3β knock-in (GSK3β 
KI) mice, which lacked the ability to phosphorylate GSK3β at the ser 389 site due 
to a serine to alanine substitution. Based on heightened fear responses previously 
observed in our lab, we predicted that increased expression GSK3β would result 
in a prolonged and heightened fear response, as GSK3β expression would 
interfere with the ability to turn off fear of a conditioned stimulus. These mutants 
were given five tone plus shock fear conditioning trials, followed by six days of 
tone alone fear extinction training. In contrast to our preliminary data, GSK3β KI 
mice did not show exaggerated conditioned fear, and showed no significant 
differences to wild type mice in fear extinction. To examine if these results were 
influenced by the age of the mice, a second study was conducted using two 
different age subsets of GSK3β KI mice. The results demonstrated that there were 
no significant differences in fear acquisition or extinction based on age. 
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Introduction 
 Traumatic experiences can have devastating effects long after the initial 
trauma itself. Traumatic fear conditioning can take place as a result of natural 
disasters, serious accidents, physical and psychological abuse, and wartime 
experiences. Over time, the concept of posttraumatic stress disorder (PTSD) was 
introduced, which began to explore how fear can last for years after even a single 
traumatic event. Psychologically, it is understood that the fear experienced during 
trauma can become associated with a specific stimulus, such as a sound or an 
image. Learning to recognize and avoid these triggers can help to reduce the 
impact of PTSD. However, there are also physiological responses that modulate 
PTSD, and by better understanding the neurobiological mechanisms in place, we 
can develop better treatments to negate these harmful effects. Recent research in 
our lab suggests that glycogen synthase kinase 3β (GSK3β) may influence these 
neurobiological mechanisms to cause exaggerated fear in mice. 
 
Functions of GSK3β 
GSK3β is a serine threonine kinase that has been implicated in having an 
active role in numerous and varied biological and psychological processes. A 
relatively rare feature found in GSK3β, (when compared to other kinases), is that 
this specific kinase is constitutively active. It is common for kinases to be inactive 
until being activated by phosphorylation, but in GSK3β the reverse is true: the 
phosphorylation of GSK3β at specific binding sites will inactivate this kinase. 
Prior research on this kinase had focused primarily on the inactivation of GSK3β 
	 4	
at the ser 9-position (Cross et al., 1995). This inactivation was accomplished by 
the phosphorylation of ser 9 by protein kinase B and occurs largely in the 
cytoplasm of neurons. 
 One previously studied interaction is the role of GSK3β in the cell 
death/cell survival signaling pathway. GSK3β was found to often induce 
apoptosis in target cells, while other times promoting cell survival (Maurer et al., 
2014). These researchers noted that PI3K, which represses cell death, also inhibits 
GSK3 activity, suggesting a possibly connection between GSK3 and cell death 
regulation. Indeed, this study suggested that GSK3 is either directly or indirectly a 
regulator of the Bcl-2 family proteins, which serve as anti-apoptotic factors, 
though its exact mechanism for this is currently unknown. Additionally, it was 
demonstrated that the lack of active GSK3β in heterozygous GSK3β knock-out 
mice (GSK+/-) was associated with impaired memory reconsolidation in contrast 
to wild-type mice (Kimura et al., 2008). Since the presence of GSK3β appears to 
be required for memory, this could suggest that overexpression of GSK3β would 
make it difficult to forget or extinguish memories.  
Behaviorally, some studies have also suggested that GSK3β may play a 
central role in mood disorders including major depressive disorder and bipolar 
disorder. One such study demonstrated that environmental and genetic factors can 
result in high levels of GSK3, leading to mood destabilization from decreased 
axonal growth and neurotransmitter release (Beurel et al., 2012). Additionally, 
lithium, (which is commonly used as a treatment for bipolar disorder), directly 
inhibits GSK3, suggesting the possibility that this inhibition may be the 
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mechanism for lithium’s effectiveness (O’Brien and Klein, 2009). As a result, 
there is interest in examining whether GSK3β inactivation may be effective as a 
therapy for varying mood disorders (Aricioglu and Gumru, 2013). 
Though there is a growing understanding of how GSK3β impacts 
apoptosis, memory, and mood disorders (among other functions), it is not known 
how (if at all) these functions are related to each other. One study on post-
traumatic stress disorder (PTSD) began to suggest a link between GSK3β 
expression and fear. In this study, PTSD- susceptible mice and PTSD-resilient 
mice were subjected to a footshock and were tested 42 days later for changes in 
brain structure (Dahlfoff, et al., 2010). In comparison to the resilient mice, the 
PTSD-susceptible mice were shown to have increased levels of phosphorylated 
GSK3β in the basolateral amygdala, a brain region well documented for its 
involvement in conditioned fear. Interestingly, these results suggest that the 
inactivation of GSK3β, not its activation, may result in prolonged and/or 
exaggerated fear.  
While the previous studies focused on the phosphorylation of GSK3β at 
the serine-9 position, a novel regulatory site of GSK3β was more recently 
discovered at the serine-389 position. The phosphorylation of this site by p38 
mitogen-activated protein kinase (p38 MAPK) and occurs largely in the nucleus 
of the neuron (Thornton et al., 2008). This finding is significant, as previous 
methods for manipulating GSK affected either the entire protein or the cytosolic 
protein, both of which are expressed throughout the body. By identifying a 
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phosphorylation site mainly localized to the neuron, we can better examine how 
nuclear GSK expression affects neuronal cell death and behavioral phenotypes.   
 
 GSK3β and fear 
Though p38 MAPK has the ability to inhibit GSK3β, there is another 
method of releasing the inhibition on GSK3β. By swapping an alanine for the 
serine at the 389 position of GSK3β, p38 is prevented from phosphorylating the 
site, leaving it GSK3β constitutively active (Thornton et al., 2008). This alteration 
produced important psychological distinctions between the GSK3β KI mice and 
the wild-type mice. While visually appearing identical to normal mice, the 
GSK3β KI mice were more prone to flee from nearby motion, as well as being 
more likely to bite and/or rattle their tails during attempts to pick them up. Some 
mice also were documented biting at the tails of siblings in their cages.  
Preliminary data from our lab noted that the GSK3β KI mice appeared to 
exhibit an overgeneralized fear response to fear conditioning, while displaying 
normal anxiety and normal maze learning. After being conditioned to fear a 
certain context, both GSK3β KI and wild-type mice exhibited a significant fear 
response (measured by the amount of time frozen in place) when placed back in 
the training context. However, GSK3β KI mice were shown to have a greater 
degree of freezing behavior than the wild-type mice. Perhaps even more 
significantly, the GSK3β KI mice also exhibited a high degree of freezing after 
fear conditioning when placed in a novel context, while wild-type mice had a 
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minimal response to a different context. This suggests that GSK3β KI mice 
experienced an overgeneralization of fear across contexts (Hare, 2015).     
Similar experiments focused on the fear exhibited to a specific tone 
instead of to a specific context. In these experiments, a significant difference 
between the GSK3β KI mice and the wild type mice was recorded. First, GSK3β 
KI and wild-type mice were conditioned to fear a specific tone. When this tone 
was played later in a new context, both GSK3β KI and wild-type mice initially 
froze to that tone. However, the wild-type mice resumed movement after a few 
minutes, while the GSK3β KI continued to freeze (Hare, 2015). Taken together, 
these results from our lab suggest that the overexpression of GSK3β may result in 
both increased acquisition and sustained duration of a conditioned fear response.  
One other intriguing finding from our recent work is the effect GSK3β 
may have on neuronal cells. While researching the behavioral effects of GSK3β, 
neuronal degradation was found in the hippocampal and cortical regions of the 
brains of GSK3β knock-in mice (Hare, 2015). This may help to explain why a 
heightened fear phenotype may be present. The hippocampus has a prominent role 
in emotion and memory, while the cortex (particularly the prefrontal cortex) can 
help to regulate brain regions such as the amygdala. With neuronal degradation 
decreasing the function of these regions, important regulation of the fear and 
memory centers may be lost.  
The purpose of this study is to better understand the contribution of 
glycogen synthase kinase 3β (GSK3β) in conditioned fear, a procedure that 
models aspects of posttraumatic stress disorder. Previous research has suggested 
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that the inability to inhibit this kinase may be associated with an enhanced 
conditioned fear response in mice. This study was designed to examine two 
hypothesized reasons to explain the previously observed increases in fear 
responses: 1) active GSK3β may enhance the acquisition of a fear response, 
producing higher initial levels of fear in comparison to wild-type mice, and/or 2) 
active GSK3β may interfere with the process of fear extinction, prolonging an 
acquired fear response for an extended duration. 
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Methods (Experiment 1) 
Subjects 
Homozygous GSK KI mice were bred in house from breeding stock 
obtained from Mercedes Rincon, Department of Immunology University of 
Vermont. GSK KI mice were on a C57BL6/J background. Age-matched wild type 
mice were purchased from Jackson Laboratory (Bar Harbor Main). A total of 18 
GSK KI and 20 wild type mice were used in the study. Mice were male and 8 
weeks of age at the start of the study. Mice were housed in groups of 4 to 5 in 
standard acrylic cages in a conventional animal facility. Food and water were 
available ad lib and the mice were on a 12-hour light dark cycle with lights on at 7 
am.   
Apparatus 
All training and testing was performed in commercially available fear 
conditioning boxes (Med Associates, St. Albans Vermont), though each box was 
modified into two distinct contexts: Context A for tone-shock pairing, and context 
B for fear extinction trials. The chambers in both contexts were inside sound 
attenuating cubicles. Context A was a darkened box with metallic walls, grid 
floor, and a nearby paper towel coated in Vicks VapoRub. For context B, an insert 
was placed in the box such that the floor was white and smooth and the walls 
made of cardboard. The smell of Vicks VapoRub from Context A was replaced by 
placing a paper towel coated in 2% anise extract solution next to the box. The 
lights in Context B were also turned on. For both contexts, an infrared camera was 
placed facing the box with the mouse inside, which was set up to record changes 
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in movement once testing began by determining the number of pixel changes in 
the image.    
Procedure 
Tone and shock fear conditioning was carried out on day 1. Mice were 
placed individually into Context A and after a two-minute acclimation period, 
presented with the first of 5 tone and shock trials at a 30 sec inter trial interval.  
Each trial consisted of a 75 dB, 4500 Hz tone for 30 seconds, ending with a 1 
second 0.3 mA footshock. At the end of conditioning, mice were returned to the 
colony room. 
 Extinction training was carried out on each of the next six days. For each 
extinction training day, mice were placed in context B. After a two-minute 
acclimation period, the mice were given a continuous three-minute tone. This 
procedure was repeated daily for a total of six days.  
 Freezing was measured with Video Freeze Software (Med Associates, St. 
Albans, Vermont) using procedures published by Anagnostaras et al., 2010.  
Data Reduction and Analysis 
The total percentage of time spent freezing to the tone over the 3-minute 
extinction trial was recorded for each day of extinction training. These data were 
subject to ANOVA, with genotype as a between subjects factor and extinction as 
a within subjects factor. For experiment one, a total of 18 GSK3β KI and 20 wild 
type mice were used. 
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Results (Experiment 1) 
 Figure 1 shows the results of the six days of fear extinction training. 
Overall, WT and KI both showed extinction over the six sessions. However, the 
differences in freezing behavior between the two groups were not enough to attain 
significance (F(5,165)=1.156, p=.333). 
 
 
          Figure 1: Experiment 1 freezing trends 
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Experiment 2 
The results of the first experiment failed to replicate the exaggerated fear 
conditioning that had previously been observed in our lab. However, previous 
work in our lab had used relatively older mice in comparison to the 8-10 week old 
mice used in Experiment 1. We hypothesized that one possible explanation for the 
behavioral differences from past experiments might be the age of the animals. In 
particular, we believed that the neuronal degradation that was found in the 
hippocampal and cortical regions of GSK3β KI mice (Hare, 2015), may be related 
to accumulated stress, thus eliciting a stronger response over time. 
Methods (Experiment 2) 
Subjects 
 Overall, twenty-one GSK3β KI and twenty wild-type mice were tested. Of 
the GSK3β KI mice, ten were 17-20 weeks old, and eleven were 10-12 weeks old. 
For the wild types, eight were 19 weeks old and twelve were 8-11 weeks old. 
Housing and all other conditions were the same as Experiment 1. 
Testing Apparatus 
Same as Experiment 1 
Procedure 
Same as Experiment 1 
Data Reduction and Analysis 
Same as Experiment 1 
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Results (Experiment 2) 
Figure 2 shows the results of the six sessions of extinction.  Overall WT mice 
showed greater extinction to the tone than KI mice (F(5,185)=3.542, p=.004). 
However, this was most likely the result of WT mice showing greater freezing to 
the tone on extinction day 1 (t(39)=2.151, p=.038). Both WT and KI mice showed 
extinction over the six sessions (F(5, 100)=9.506, p=.000; F(5,95)=14.042, 
p=.000, KI and WT respectively).  
 
 
          Figure 2: Experiment 2 freezing trends   
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    Figure 3: KI freezing differences based on age 
 
  Figure 4: WT freezing differences based on age 
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Discussion 
 Overall, no significant differences were found between the GSK3β knock-
ins and the wild type mice. Though consistent fear responses were elicited to the 
tone stimulus, the initial amount of freezing, while varying greatly among 
individual mice, was demonstrated on average to be similar between GSK3β KI 
and WT mice. Additionally, the rate of fear extinction over the six-day extinction 
training period was also similar between both cohorts of mice.  
 During the second experiment, two age groups were run to see if GSK3β 
KI mice exhibited any differences in response based on age. While age was 
considered as a possible factor in the ability to extinguish fear, there had been no 
evidence to date linking the two. While the results from this replication did 
indicate a moderate increase in the initial level of fear for older KI mice, the older 
wild-types run as a control similarly exhibited an increased initial level of fear. 
Within each group, the rate of fear extinction was nearly identical between older 
and younger mice. Thus, the GSK3β knock-ins did not display any significant 
differences in either acquisition of fear or extinction of fear based on age.  
 In Experiment 2, the only significant result was found to be between the 
average freezing between KI and WT mice, regardless of age. This is in contrast 
to the results of Experiment 1, where no significance was achieved. However, it is 
most likely that the significance from Experiment 2 is a result of the heightened 
fear response in the wild type mice on day 1 of extinction training. While it is 
theoretically possible that the trends observed could indicate that the KI mice are 
demonstrating a decreased rate of fear extinction in comparison to the wild types, 
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this result more likely demonstrates an increased fear acquisition in the wild 
types. 
 As often happens when conducting scientific experiments, the results from 
this study have generated more questions than from the beginning. Chief among 
those questions is why there is a discrepancy between these results (in not finding 
a conclusive link between GSK3β and either fear acquisition of extinction) and 
from previous work in the Falls lab, which had found what appeared to be a 
connection between GSK3β and fear.  
 One possible explanation is that the premise of this experiment is based 
off of a type I error. As stated previously, many individual mice (in both the 
GSK3β KI and wild-type groups) displayed great variability in both their 
acquisition of the fear response as well as their relative rate of fear extinction. 
Indeed, early in the process of conducting Experiment 1, (albeit with a small 
number of mice run at this point), there appeared to be a clear difference between 
the GSK3β knock-ins and the wild types. It is plausible that the previous work in 
this lab noticed a fear response that is nothing more than statistical variability in 
this behavioral response, and that on average there is no significant difference 
between GSK3β knock-ins and wild types where fear is concerned. 
 There is also a confounding factor that we later noted that may have 
influenced the results. Though care was taken to ensure the conditions of the 
experiment itself were consistent for all mice tested, the same cannot be said for 
the upbringing of said mice. In years past, both the GSK3β KI mice and the wild-
type mice had been sourced from another lab. At the beginning of this 
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experiment, multiple GSK3β breeding pairs were created meaning that all GSK3β 
mice used in this experiment where born and raised in the same colony room.  
Unfortunately, the wild types used in this experiment were purchased and 
not bred in house. The process of shipping the mice across multiple states, 
followed by the potential stressors of different types of bedding, different cages, 
and different room environment (among others) may have introduced a 
confounding variable. Tuli et al. (1995) found that normal mouse behaviors such 
as climbing, grooming, feeding, and sexual activity all underwent significant 
changes after transportation, with acclimatization often lasting more than four 
days. It is therefore possible that the transportation of these mice activated a long-
term stress pathway that caused a heightened fear response during testing. Future 
studies in this area should ensure that the upbringing conditions be similar for all 
groups of mice involved in the testing.   
 While not explaining the discrepancy between previous and current data 
regarding GSK3β KI extinction trends, it may also be beneficial in future studies 
to find a way to selectively activate GSK3β in specific areas of the brain. Both of 
the methods used in the Falls lab (either knocking in the GSK3β gene or knocking 
out its inhibitor, p38) result in GSK3β being constrictively active throughout the 
entire brain and body. Thus, any effects (or lack thereof) that we observe may be 
influenced by how GSK3β interacts with multiple body systems. If methods were 
developed to selectively activate GSK3β in, say, the amygdala or the prefrontal 
cortex, we may be able to learn more about how GSK3β might play a role in the 
learning or extinguishing of fear. On a related track, it may also prove useful to 
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stain brain sections to determine where GSK3β is active in normal mice, and 
attempt to determine what conditions would cause the gene to be more or less 
active than usual.    
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